Octagon Therapeutics
3 known investors
Octagon Therapeutics develops medicines for patients with autoimmune and inflammatory diseases such as lupus, multiple sclerosis, Sjögren's, and myositis. It targets immune checkpoint receptors to restore immune homeostasis, using insights into the glycoproteome to identify disease-driving biology.